Genobyte
GenoByte, in partnership with PRECISYA Global, USA, offers a personalized precision health service based on comprehensive human genome analysis. They leverage big data and AI-enabled proprietary algorithms to analyze over 26,000 genes and 6 million genetic variations per person. Their offerings include a wide array of advanced genetic panels tailored for various medical disciplines, such as Metabolic Pathways, Longevity, Cardiovascular, and Neurodegenerative panels. GenoByte's methodology goes beyond typical exome analysis by also examining introns, providing a more holistic view of genetic information and its impact on health, disease predisposition, and treatment outcomes. Their unique Strand Inversion Algorithm reportedly increases accuracy by over 24% compared to global laboratories. The company has a proven track record, with over 2.5 million genomic tests administered over seven years, serving more than 300,000 consumer health patients and utilized by over 4,000 healthcare practitioners.
Genobyte
GenoByte, in partnership with PRECISYA Global, USA, offers a personalized precision health service based on comprehensive human genome analysis. They leverage big data and AI-enabled proprietary algorithms to analyze over 26,000 genes and 6 million genetic variations per person. Their offerings include a wide array of advanced genetic panels tailored for various medical disciplines, such as Metabolic Pathways, Longevity, Cardiovascular, and Neurodegenerative panels. GenoByte's methodology goes beyond typical exome analysis by also examining introns, providing a more holistic view of genetic information and its impact on health, disease predisposition, and treatment outcomes. Their unique Strand Inversion Algorithm reportedly increases accuracy by over 24% compared to global laboratories. The company has a proven track record, with over 2.5 million genomic tests administered over seven years, serving more than 300,000 consumer health patients and utilized by over 4,000 healthcare practitioners.